Literature DB >> 16957873

Clinical characteristics and objective living conditions in relation to quality of life among community-based individuals of schizophrenia in Hong Kong.

Frederick Ka Ching Yeung1, Sunny Ho Wan Chan.   

Abstract

Quality of life (QOL) has gained importance as an outcome measure for people with schizophrenia living in the community following deinstitutionalization. This study aims at exploring the effects of clinical characteristics and objective living conditions on QOL. In this study, 201 community-based individuals with schizophrenia were recruited from five different types of objective living conditions comprising long stay care home, halfway house, supported hostel/housing, living with family, and living alone. Clinical characteristics including cognitive abilities, symptom levels, and community/social functioning were assessed by the Allen Cognitive Level Screen, the Scales for the Assessment of Negative Symptoms and Positive Symptoms, and the Chinese version of the Multnomah Community Ability Scale respectively. The outcome measure of QOL was measured by the Chinese version of the WHO Quality of Life Measure. Analysis of covariance showed significant differences in community/social functioning, cognitive abilities, and negative symptoms; but not in QOL under different objective living conditions. Further simultaneous multiple regressions found out that community/social functioning was the robust significant predictor of QOL. Yet caution should be noted in making the conclusion with the objective living condition of long stay care home, as it provides a protective element for the perseverance of QOL.

Entities:  

Mesh:

Year:  2006        PMID: 16957873     DOI: 10.1007/s11136-006-0006-z

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  49 in total

1.  Does the place of treatment influence the quality of life of schizophrenics?

Authors:  W Rössler; H J Salize; G Cucchiaro; I Reinhard; C Kernig
Journal:  Acta Psychiatr Scand       Date:  1999-08       Impact factor: 6.392

2.  The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale.

Authors:  R M Norman; A K Malla; T McLean; L P Voruganti; L Cortese; E McIntosh; S Cheng; A Rickwood
Journal:  Acta Psychiatr Scand       Date:  2000-10       Impact factor: 6.392

3.  Intervention research in psychosis: issues related to the assessment of quality of life.

Authors:  A G Awad; L N Voruganti
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

4.  Adolescent performance on the Allen Cognitive Levels Screen.

Authors:  Sloane Nguyen Lee; Audrey Gargiullo; Sara Brayman; Jodi Coppage Kinsey; Hope Carroll Jones; Mary Shotwell
Journal:  Am J Occup Ther       Date:  2003 May-Jun

5.  Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial.

Authors:  Wai-Kwong Tang; Gabor S Ungvari
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-05       Impact factor: 5.067

6.  Quality of life of long-stay patients discharged from two psychiatric institutions.

Authors:  J Leff; D Dayson; C Gooch; G Thornicroft; W Wills
Journal:  Psychiatr Serv       Date:  1996-01       Impact factor: 3.084

7.  From Leros asylum to community-based facilities: levels of functioning and quality of life among hostel residents in Greece.

Authors:  A Zissi; M M Barry
Journal:  Int J Soc Psychiatry       Date:  1997

8.  An overview of surveys of mental health consumers' preferences for housing and support services.

Authors:  B Tanzman
Journal:  Hosp Community Psychiatry       Date:  1993-05

9.  Hospital and community-based care for patients with chronic schizophrenia in Hong Kong--quality of life and its correlates.

Authors:  Grace W L Chan; Gabor S Ungvari; Daniel T L Shek; John J P Leung Dagger
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2003-04       Impact factor: 4.328

10.  Social integration and the quality of life of schizophrenic patients in different types of complementary care.

Authors:  M Leisse; T W Kallert
Journal:  Eur Psychiatry       Date:  2000-12       Impact factor: 5.361

View more
  8 in total

1.  The RSM-scale: a pilot study on a new specific scale for self- and observer-rated quality of life in patients with schizophrenia.

Authors:  M Riedel; I Spellmann; R Schennach-Wolff; M Obermeier; R Musil
Journal:  Qual Life Res       Date:  2010-10-05       Impact factor: 4.147

2.  Associated and mediating variables related to quality of life among service users with mental disorders.

Authors:  Marie-Josée Fleury; Guy Grenier; Jean-Marie Bamvita
Journal:  Qual Life Res       Date:  2017-10-11       Impact factor: 4.147

3.  Quality of life of patients with schizophrenia treated in foster home care and in outpatient treatment.

Authors:  Mate Mihanović; Branka Restek-Petrović; Anamarija Bogović; Ena Ivezić; Davor Bodor; Ivan Požgain
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-05       Impact factor: 2.570

4.  Pattern of disability among persons who availed half-way home-care services for psychosocial rehabilitation.

Authors:  M Ranganathan; Sinu Ezhumalai; Samir Kumar Praharaj
Journal:  Ind Psychiatry J       Date:  2012-07

5.  Qualities of Life of Patients with Psychotic Disorders and Their Family Caregivers: Comparison between Hospitalised and Community-Based Treatment in Beijing, China.

Authors:  Lizheng Guan; Yingqiang Xiang; Xin Ma; Yongzhen Weng; Wannian Liang
Journal:  PLoS One       Date:  2016-11-21       Impact factor: 3.240

6.  Tai-chi for residential patients with schizophrenia on movement coordination, negative symptoms, and functioning: a pilot randomized controlled trial.

Authors:  Rainbow T H Ho; Friendly S W Au Yeung; Phyllis H Y Lo; Kit Ying Law; Kelvin O K Wong; Irene K M Cheung; Siu Man Ng
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-24       Impact factor: 2.629

7.  The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy.

Authors:  William Montgomery; Li Liu; Michael D Stensland; Hai Bo Xue; Tamas Treuer; Haya Ascher-Svanum
Journal:  Clinicoecon Outcomes Res       Date:  2013-08-14

8.  Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?

Authors:  William Montgomery; Tamas Treuer; Wenyu Ye; Hai Bo Xue; Sheng Hu Wu; Li Liu; Zbigniew Kadziola; Michael D Stensland; Haya Ascher-Svanum
Journal:  Neuropsychiatr Dis Treat       Date:  2014-07-10       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.